KennethE.ShermanMDPhD

Hepatology & Liver Transplantation

Distinguished University Research Professor and Emeritus Professor of Medicine- University of Cincinnati College of Medicine Physician in Medicine- Massachusetts General Hospital

Join to view full profile

Dr. Sherman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sherman's full profile

Already have an account?

Office
Gastroenterology Division
55 Fruit Street
Boston, MA 02114

Summary

Dr. Kenneth Sherman is a gastroenterologist based in Boston, MA, with subspecialties in hepatology and liver transplantation. He completed his medical education at George Washington University School of Medicine and Health Sciences and residency in internal medicine at Tripler Army Medical Center. He further specialized in gastroenterology at Fitzsimons Army Medical Center. Currently, he is a physician at Massachusetts General Hospital and has longstanding roles as Division Chief at University of Cincinnati Medical Center and Professor Emeritus at University of Cincinnati College of Medicine. Dr. Sherman is experienced in general gastroenterology, hepatology, and various liver diseases including viral hepatitides and non-alcoholic fatty liver disease. His recent publications and clinical trials focus on hepatitis and liver transplantation. He is recognized as a Fellow by several prestigious organizations, including the American Gastroenterologic Association and the American Association for the Study of Liver Diseases.

Education & Training

Fitzsimons Army Medical CenterGastroenterology, 1989 - 1991
Tripler Army Medical CenterResidency, Internal Medicine, 1985 - 1988
George Washington University School of Medicine and Health SciencesClass of 1985
Rutgers UniversityPhD, Microbiology, Busch Pre-doctoral Fellowship, 1976 - 1980

Certifications & Licensure

MA State Medical License 2019 - 2026
OH State Medical License 1994 - 2026
CO State Medical License 1991 - 2011
NJ State Medical License 1987 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow American Gastroenterologic Association, 2017
AOA Alpha Omega Alpha- University of Cincinnati
Fellow, American Association for the Study of Liver Diseases AASLD, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow, American College of Physicians American College of Physicians
Fellow (FACG) American College of Gastroenterology
Join now to see all

Clinical Trials

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
Withdrawn
Phase 2
Treatment of Hepatitis C in Hemophilic Patients With HIV Start of enrollment: 2002 Mar 01
Completed
Phase 2
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) Start of enrollment: 2004 Jul 01
Completed
Phase 2
Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV Start of enrollment: 2006 Apr 01
Completed
Phase 1
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response Start of enrollment: 2008 Oct 01
Completed
Phase 3
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
Completed
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection Start of enrollment: 2012 Apr 01
Completed
Phase 3
Viral Kinetics in HCV Clearance in Subjects With Hemophilia Start of enrollment: 2012 Dec 01
Completed
Phase 1
Study of Oral Treatments for Hepatitis C Start of enrollment: 2016 Jun 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Case 6-2025: A 62-Year-Old Man with Abdominal Pain.
Gabrielle K Bromberg, Robert G Rasmussen, Kenneth E Sherman, Sanjeeva P Kalva, Katayoon Goodarzi
The New England Journal of Medicine. 2025-02-20
1 citations
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
Kristen M Marks, Minhee Kang, Triin Umbleja, Andrea Cox, Karen J Vigil
JAMA. 2025-01-28
Outcomes following the use of HBsAg-positive liver allografts in HBsAg-negative recipients.
Adam S Myer, Drake A Seccurro, Kenneth E Sherman, Yeshika Sharma
Liver Transplantation. 2024-11-08

Other

Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient
Sherman KE, McGovern BH
http://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-hepatitis-b-i
UpToDate, Wolters Kluwer Health - 2013-01-31
Antiviral medications for the treatment of hepatitis B in the HIV-infected patient
Sherman KE, McGovern BH
http://www.uptodate.com/contents/antiviral-medications-for-the-treatment-of-hepatitis-b-in-the-hiv-i
UpToDate, Wolters Kluwer Health - 2011-02-18
Evaluation of chronic hepatitis B virus infection in the HIV-infected patient
Sherman KE, McGovern BH
http://www.uptodate.com/contents/evaluation-of-chronic-hepatitis-b-virus-infection-in-the-hiv-infect
UpToDate, Wolters Kluwer Health - 2013-01-10
Monitoring the HIV-infected patient with chronic hepatitis B virus infection
Sherman KE, McGovern BH
http://www.uptodate.com/contents/monitoring-the-hiv-infected-patient-with-chronic-hepatitis-b-virus-
UpToDate, Wolters Kluwer Health - 2013-01-03
Prevention of hepatitis B virus infection in the HIV-infected adult
Sherman KE, McGovern BH
http://www.uptodate.com/contents/prevention-of-hepatitis-b-virus-infection-in-the-hiv-infected-adult
UpToDate, Wolters Kluwer Health - 2013-02-05
Treatment of hepatitis B in the HIV-infected patient
Sherman KE, McGovern BH
http://www.uptodate.com/contents/treatment-of-hepatitis-b-in-the-hiv-infected-patient
UpToDate, Wolters Kluwer Health - 2012-09-28
Join now to see all

Press Mentions

People with HIV Can Be Protected Against Hepatitis B with a Three-Dose Vaccine RegimenOctober 24th, 2022
Extra Hep B Vaccine Dose Exceeds Expectations for People with HIVOctober 23rd, 2022
Medical News Today: Liver Health in HIV: This Gene Indicates New Therapeutic TargetsDecember 14th, 2019
Join now to see all

Grant Support

Liver Disease And HIVNational Institute Of Allergy And Infectious Diseases2006–2012
Mentorship In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2012
Antiretroviral Therapy And The Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases2006–2010
Antiretroviral Therapy And HCV/HIVNational Center For Research Resources2008
Response Of Hepatitis C Virus To Interferon In Hemophilic PatientsNational Center For Research Resources2005–2006
Hepatitis C Virus Response To Interferon In HemophiliaNational Center For Research Resources2004
HCV Genomic Variability In HIV Infected HemophiliacsNational Institute Of Allergy And Infectious Diseases2001–2004
Health Utilities In Hepatitis C Infected PatientsAgency For Healthcare Research And Quality1999